Rapid Growth of Botulinum Toxin in China's Aesthetic Medicine Market

The Chinese market of botulinum toxin expands rapidly and is expected to reach 14 billion RMB in 2025. More foreign companies are starting to bring their botulinum toxin products to China.
by Yinpeng Feng Apr 07, 2021

Aesthetic medicine market in China is growing rapidly in recent years due to the increase of Chinese people's disposable income and the innate desire for beauty. With the major function to reduce the appearance of skin wrinkle, botulinum toxin injection has become one of the most favorable aesthetic medicine products by Chinese customers. The market size of botulinum toxin in China reached 3.92 billion RMB in 2018 and is expected to reach 14 billion RMB in 2025. The compound annual growth rate from 2015 to 2018 was 30.8%.1

Yinpeng Feng
ChemLinked Regulatory Analyst
Copyright: unless otherwise stated all contents of this website are ©2021 - REACH24H Consulting Group - All Rights Reserved - For permission to use any content on this site, please contact cleditor@chemlinked.com